DP, F., KL, C., L, J., & JF, R. (2004). Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer. British journal of cancer, 90(3), 590. https://doi.org/10.1038/sj.bjc.6601557
Chicago Style (17th ed.) CitationDP, Forward, Cheung KL, Jackson L, and Robertson JF. "Clinical and Endocrine Data for Goserelin Plus Anastrozole as Second-line Endocrine Therapy for Premenopausal Advanced Breast Cancer." British Journal of Cancer 90, no. 3 (2004): 590. https://doi.org/10.1038/sj.bjc.6601557.
MLA (9th ed.) CitationDP, Forward, et al. "Clinical and Endocrine Data for Goserelin Plus Anastrozole as Second-line Endocrine Therapy for Premenopausal Advanced Breast Cancer." British Journal of Cancer, vol. 90, no. 3, 2004, p. 590, https://doi.org/10.1038/sj.bjc.6601557.